Sanofi’s Easier to Use Hemophilia Drug Approved by US FDA
Sanofi’s treatment for hemophilia that can be administered as infrequently as once every other month, was approved by the US ...
Wall Street Worries FDA Cuts Will Slow Drug Approvals
Steep cuts at the Food and Drug Administration might slow down drug approvals vital to the biopharma industry.
FDA broadens use of Novartis’ radiopharma drug Pluvicto
Pluvicto can now be used before chemotherapy to treat a kind of metastatic prostate cancer, tripling the number of patients ...
FDA approves first new UTI drug in decades
The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...
MedPage Today on MSN1d
FDA OKs First Drug for Hyperphagia in Prader-Willi Syndrome
Diazoxide choline is the first drug indicated for hyperphagia in the rare genetic disorder. Prior to approval, people with ...
Facing high costs and drug shortages, they turned to compounded weight loss drugs online. An FDA ban might end that.
Is the era of sourcing cheaper weight loss drugs from the internet over? High demand for GLP-1 agonists — prescription drugs ...
US FDA greenlights GSK's drug for UTIs in women and girls
The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in ...
FDA approves new drug to treat protein buildup in the heart
The FDA has approved a new drug for a serious heart condition that affects thousands of people. The drug, called Amvuttra ...
First Prader-Willi drug to reduce hunger approved by FDA
Clearance of Vykat unlocks what analysts anticipate will be a lucrative market opportunity for Soleno Therapeutics.
FDA's top vaccine official forced out, decries RFK Jr.'s "misinformation and lies"
A Department of Health and Human Services official delivered an ultimatum to Dr. Peter Marks: either resign or be fired.
STAT9h
Peter Marks, FDA’s top vaccine regulator, forced out
Top FDA official Peter Marks was forced to resign as the director of the Center for Biologics Evaluation and Research.
STAT1d
Two of FDA’s top cancer regulators to depart, heightening worries about drug reviews
Deputy directors at the FDA center that oversees the regulation of cancer drugs plan to leave, adding to a flood of top ...